News

New technique protects 'architecture' of insulin-producing islet cells for transplant into type 1 diabetics
Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic ...
GIP receptor shows surprising dual action: Both activation and blockade support weight loss
Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and ...
Hims & Hers to Sell Novo Nordisk's Wegovy in U.S., Shares Soar -- Update
In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering ...
Retatrutide (LY3437943): A Novel Tri-agonist Peptide for Metabolic Disease Treatment
TUCSON, AZ / ACCESS Newswire / April 29, 2025 / Retatrutide, also known as LY3437943, is an innovative triple receptor agonist targeting glucose-dependent insulinotropic polypeptide (GIP), ...